A minority 8% of the respondents opined that other types of vaccines are the most promising. The analysis is based on 373 responses received between 08 July and 10 August from readers of Pharmaceutical Technology, a Verdict network site.
Scientists and pharmaceutical companies are following different approaches to developing vaccines against coronavirus. The vaccine being developed by Oxford University in partnership with AstraZeneca is the first to show efficacy against the coronavirus.
It is an adenovirus vaccine vector designed to generate an immune response. Another leading vaccine being developed by Johnson & Johnson/Janssen Pharmaceuticals is also an adenovirus vaccine vector, while those being developed by Merck, Sharpe &.